← Back to Clinical Trials
Recruiting NCT07249008

NCT07249008 NSS Grocery Store Brazil

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07249008
Status Recruiting
Phase
Sponsor George Washington University
Condition Control Group
Study Type INTERVENTIONAL
Enrollment 1,068 participants
Start Date 2026-02-15
Primary Completion 2026-06-30

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Experimental : Mexico-based NSS FOPLExperimental : Brazil-based NSS FOPL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 1,068 participants in total. It began in 2026-02-15 with a primary completion date of 2026-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to assess the impact of non-sugar sweeteners (NSS) front-of-package labels (FOPL) on Brazilian parents' food and beverage selections for their children. The study includes three arms: 1. no NSS FOPL control group, 2. a group exposed to a NSS FOPL modeled after the Mexican warning label for NSS, and 3. a group exposed to a NSS FOPL using the magnifying glass symbol currently implemented in Brazil for nutrients of public health concern. Participants will be instructed to select products for their child, including one yogurt, three beverages (for breakfast, lunch, and dinner), one granola, and one cereal bar.

Eligibility Criteria

Eligible participants include: * Adults aged 20 years or older, * Living in Brazil * Parents or guardians of children between 2 and 12 years old * Primarily responsible for the household grocery shopping (more than 50%) * Can read and understand Portuguese Recruitment will occur nationwide through an online panel, with quotas for education, race, and geographic distribution to approximate the national profile. Individuals will be excluded if * Not a parent or guardian of a child aged 2-12 years * Younger than 20 years * Not primarily responsible for more than half of the household grocery shopping * Unable to read or understand Portuguese * Do not provide informed consent.

Contact & Investigator

Central Contact

Allison C Sylvetsky, PhD

✉ asylvets@email.gwu.edu

📞 +1 202-994-9412

Frequently Asked Questions

Who can join the NCT07249008 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, studying Control Group. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07249008 currently recruiting?

Yes, NCT07249008 is actively recruiting participants. Contact the research team at asylvets@email.gwu.edu for enrollment information.

Where is the NCT07249008 trial being conducted?

This trial is being conducted at Washington D.C., United States.

Who is sponsoring the NCT07249008 clinical trial?

NCT07249008 is sponsored by George Washington University. The trial plans to enroll 1,068 participants.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology